Skip to main content

Table 6 Device-oriented endpoint within 36 months

From: Clinical results of bioresorbable drug-eluting scaffolds in short and long coronary artery lesions using the PSP technique

 

Total

Lesion length < 20 mm

Lesion length ≥ 20 mm

P-Value

Number of lesions

179

121

58

 

Scaffold thrombosis, N (%)

3 (1.1)

3 (1.7)

0 (0.0)

0.12

TLR, N (%)

11 (6.1)

5 (4.1)

6 (10.3)

0.08

MI, N (%)

8 (4.5)

5 (4.1)

3 (5.2)

0.21

Number of patients

139

84

55

 

DoCE, N (%)

16 (11.5)

8 (9.5)

8 (14.6)

0.37

Cardiac mortality, N (%)

5 (3.6)

3 (3.6)

2 (3.6)

0.95

  1. TLR ischemia-driven target lesion revascularization, MI myocardial infarction, not clearly related to a non-target vessel; DoCE device-oriented endpoints